Medical Countermeasures UK Commits £33.2 Million to Eight Vaccine Projects Targeting Ebola, Marburg, Plague and Other Epidemic ThreatsGlobal Biodefense StaffOctober 18, 2026
Research New Research Reveals How Seminal Fluid Actively Amplifies Mpox InfectivityGlobal Biodefense StaffSeptember 12, 2026
Defense + Military Pentagon Pain-Medication EUA Pathway Opens Amid Ongoing Iran ConflictGlobal Biodefense StaffSeptember 4, 2026
Macaques Show Protective Immunity Against SARS-Cov-2 After Infection or Vaccine Medical Countermeasures May 20, 2020 …
COVID-19 Cytokine Storm: Possible Mechanism for the Deadly Respiratory Syndrome Medical Countermeasures May 20, 2020 …
The Challenges of Developing a Safe and Effective COVID-19 Vaccine Medical Countermeasures May 12, 2020 …
NAU Launches Testing Service Center to Evaluate COVID-19 Drug Candidates Medical Countermeasures May 9, 2020 …
NIAID to Hold Closed Meeting on Biodefense Medical Countermeasure Funding Contracts + Grants May 7, 2020 …
Inactivated Vaccine Candidate Protects Macaques From SARS-Cov-2 Infection Medical Countermeasures May 6, 2020 …
NYU Langone Health Enrolling Patients in US Clinical Trial For COVID-19 mRNA Vaccine Medical Countermeasures May 5, 2020 …
Hydroxychloroquine Linked to Increased Risk of Cardiac Arrhythmia Medical Countermeasures May 1, 2020 …
Pharmacists Warn Against Malarial Drugs as a Cure for Coronavirus Medical Countermeasures April 30, 2020 …
NUS-Led Team Develops Artificial Intelligence Platform to Combat Infectious Diseases Medical Countermeasures April 27, 2020 …
Emergex and GMU’s National Center for Biodefense and Infectious Diseases Partner for Highly Pathogenic RNA Virus Studies Industry News April 22, 2020 …
Researchers Develop New Microneedle Array Combination Vaccine Delivery System Medical Countermeasures April 21, 2020 …
Convalescent Plasma Therapy: Johns Hopkins Releases Guidebook, Penn Medicine and UChicago Start Trials Medical Countermeasures April 20, 2020 …
Alexion to Initiate Phase 3 Study of Rare Blood-Disorder Drug in Severe COVID-19 Patients Medical Countermeasures April 20, 2020 …
Novartis to Start Large, Randomized Trial of Hydroxychloroquine in Hospitalized COVID-19 Patients Medical Countermeasures April 20, 2020 …
Investigational Chimp Adenovirus MERS-CoV Vaccine Protects Monkeys Medical Countermeasures April 17, 2020 …
Antiviral Remdesivir Prevents Disease Progression in Monkeys with COVID-19 Medical Countermeasures April 17, 2020 …
